Antifungal Drugs Market size is valued at USD 15,623.8 million in 2021 and is expected to grow at a CAGR of 3.9% during the forecast period 2022 to 2028. The global market provides a detailed overview and that can be segmented by drug type, by route of administration, by Therapeutic indication, and by distribution channel. By drug type, the Antifungal Drugs market growth has been segmented into Azoles, Polyenes, Echinocandins, Allylamines, and Others. The Azoles segment is likely to be the largest and fastest-growing segment in terms of drug type. Azoles are used to treat candidemia, blastomycosis, ocular fungal infections, and systemic candidiasis. It helps in fungistatic activities by hindering fungal enzymes. Azoles are also utilized in the treatment of systemic fungal infections, divided into imidazoles and triazoles. They provide an extensive spectrum of activity along with improved safety levels. Triazoles have less severe effects, fewer serious drug interactions, and enhanced distribution and absorption properties. The above-mentioned advantages of the use of azoles are attributed to the antifungal drug market share. Based on the Route of administration, the Antifungal Drugs market is segmented into Oral, Parenteral, and Topical. Among these, the Topical route of administration segment is expected to have a significantly growing market during the forecast period 2022-2028. Based on the Therapeutic indication, the Antifungal Drugs market is segmented into Aspergillosis, Candidiasis, Dermatophytosis, and Others. The Candidiasis segment is expected to have a significant share in 2021. Candidiasis is the most frequently happening systemic fungal infection. It is a yeast infection by the genus Candida. Its process to cure has changed over time. Some of the variations comprise suitable usage of broad-spectrum azoles and echinocandins for treatment of candidemia, invasive candidiasis, and mucosal candidiasis. Based on the distribution channel, the Antifungal Drugs market is segmented into Retail pharmacies, Hospital pharmacies, Drug stores, and Online pharmacies.
In June 2021, Mankind Pharma launched Posaconazole Gastro which was a tablet for drug resistance.
In June 2021, Cadila Pharmaceuticals launched Posaconazole which can be used against an extensive range of fungal disorders.